Kiniksa Pharmaceuticals International, plc Quarterly Unrecognized Tax Benefits in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Kiniksa Pharmaceuticals International, plc quarterly Unrecognized Tax Benefits history and growth rate from Q4 2017 to Q4 2023.
  • Kiniksa Pharmaceuticals International, plc Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $1.79M, unchanged year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $1.79M $0 0% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $1.79M +$1.25M +229% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $545K -$292K -34.9% Dec 31, 2021 10-K 2024-02-28
Q4 2020 $837K +$309K +58.5% Dec 31, 2020 10-K 2024-02-28
Q4 2019 $528K +$528K Dec 31, 2019 10-K 2023-03-02
Q4 2018 $0 $0 Dec 31, 2018 10-K 2020-03-05
Q4 2017 $0 Dec 31, 2017 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.